6-acetylaminocaproic acid has been researched along with Osteoporosis in 2 studies
6-acetylaminocaproic acid: wound-healing agent component of plasmutan
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamaguchi, M | 2 |
| Uchiyama, S | 1 |
| Igarashi, A | 1 |
2 other studies available for 6-acetylaminocaproic acid and Osteoporosis
| Article | Year |
|---|---|
Preventive effect of zinc acexamate administration in streptozotocin-diabetic rats: Restoration of bone loss.
Topics: Alkaline Phosphatase; Aminocaproates; Aminocaproic Acid; Animal Feed; Animals; Body Weight; Bone and | 2003 |
Increase in bone protein components with healing rat fractures: enhancement by zinc treatment.
Topics: Alkaline Phosphatase; Aminocaproates; Aminocaproic Acid; Animals; Biomarkers; Cycloheximide; DNA; Fe | 1999 |